Commentators often portray John Jacob Abel (1851-1938) as the father o
f American pharmacology and the inventor of the artificial kidney mach
ine. In this paper, I outline his career and examine the background to
his experiments in 'vividiffusion' (dialysis in vivo) as a prelude to
re-examining the published details of his experiments. I then compare
the text of his medical publications on the subject with contemporary
reports that appeared in the lay press and with the data contained in
his laboratory note-books. I cite evidence that Abel's private aims d
iffered markedly from his public claims, examine why he abandoned dial
ysis in favour of 'plasmaphaeresis' for the treatment of uraemia, and
mention some unfortunate consequences of that change. Finally, I exami
ne the background to Abel's explanation that the unavailability of hir
udin caused him to discontinue dialysis experiments, and raise the pos
sibility that this provided him with a convenient method of escape fro
m a field that threatened his reputation. I conclude that Aber's exper
iments with dialysis in vivo were not designed to control renal failur
e, but rather to isolate new hormones from the blood.